Abstract:Progress in the development of manganese oxide nanoparticles (MONPs) has offered an alternative to the current Gd-based T 1 magnetic resonance image (MRI) contrast agents for early-stage diagnosis of life-threatening diseases. MONPs also possess unique self-degradation characteristics, making them suitable for the therapeutic delivery of drugs and genes. Advances in the NP synthesis and characterisation, especially fundamental insights into the thermodynamically and kinetically controlled growth of NP and rich surface chemistry offering conjugation of biomolecules and polymers to its surface, have enabled the reproducible production of multifunctional targeted MONPs in various sizes and shapes. The integration of diagnosis and therapeutic capabilities within a single entity, so-called “nanotheranostics”, has offered new hope for using them for simultaneous real-time monitoring of disease progression in response to the treatment, thus evaluating the efficacy of therapeutic treatment. In this review, we highlight the recent advancements in the synthesis of MONPs and functionalisation strategies used to realise their theranostic potential. We discuss the basic physics of MR imaging and factors influencing the contrast enhancement mechanism of MONPs and review the use of multifunctional MONPs for dual and multimodal imaging and therapeutic delivery applications. This review also discusses how the biological properties of MONPs can influence their performance in a biological environment, including induced toxicity, which should be taken into consideration for designing next-generation engineered precision MONPs for disease diagnosis and treatment. Finally, we also provide a forward-looking perspective to accelerate the translation of MONPs into the clinical setting.

Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics

Manganese Oxide Nanoparticles As MRI Contrast Agents in Tumor Multimodal Imaging and Therapy

Manganese-based contrast agents for MRI

Structure-property Relationships in Manganese Oxide - Mesoporous Silica Nanoparticles Used for T1-weighted MRI and Simultaneous Anti-Cancer Drug Delivery

Ultrahigh Relaxivity and Safe Probes of Manganese Oxide Nanoparticles for in Vivo Imaging.

Manganese complexes and manganese-based metal-organic frameworks as contrast agents in MRI and chemotherapeutics agents: Applications and prospects

Rational Design of Magnetic Nanoparticles as T1–T2 Dual-Mode MRI Contrast Agents

Manganese oxide nanoplatforms for disease diagnosis and treatment: Progress, challenges and opportunities

Advancements in manganese complex-based MRI agents: Innovations, design strategies, and future directions

Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive T1-Weighted Contrast-Enhanced Brain Imaging

Ultra-small Manganese Dioxide Nanoparticles with High T1 Relaxivity for Magnetic Resonance Angiography.

A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents

Mn(ii) Chelate-Coated Superparamagnetic Iron Oxide Nanocrystals As High-Efficiency Magnetic Resonance Imaging Contrast Agents

Biocompatible and pH-sensitive PLGA encapsulated MnO nanocrystals for molecular and cellular MRI

Review on Medical Applications of Manganese Oxide (Mn2+, Mn3+, and Mn4+) Magnetic Nanoparticles

Advances in the application of manganese dioxide and its composites for theranostics

Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive T 1 -Weighted Contrast-Enhanced Brain Imaging

Tuneable Manganese Oxide Nanoparticle Based Theranostic Agents for Potential Diagnosis and Drug Delivery

Progress in research of magnetic resonance imaging of manganese contrast agent

Biocompatible Caramelized Carbonaceous Nanospheres Supported Paramagnetic Ultrathin Manganese Oxide Nanosheets Via Self-Sacrificing Reduction As a MRI Contrast Agent for Liver Imaging

Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for In Vivo Dual-Modality Positron Emission Tomography and Magnetic Resonance Imaging.